Literature DB >> 21253898

Small colony variants of Staphylococcus aureus--review.

O Melter1, B Radojevič.   

Abstract

Bacterial variants of Staphylococcus aureus called small colony variants (SCVs) originate by mutations in metabolic genes, resulting in emergence of auxotrophic bacterial subpopulations. These variants are not particularly virulent but are able to persist viable inside host cells. SCVs show their characteristic auxotrophic growth deficiency and depressed α-cytotoxin activity. Environmental pressure such as antibiotics, select for isogenic SCV cells that are frequently found coexisting with their parent wild-type strains in a mixed bacterial culture. SCV strains often grow on blood agar as non-pigmented or pinpoint pigmented colonies and their key biochemical tests are often non-reactive. Their altered metabolism or auxotrophism can result in long generation time and thus SCV phenotype, more often than not SCV can be overgrown by their wild-type counterparts and other competitive respiratory flora. This could affect laboratory detection. Thus, molecular methods, such as 16S rRNA partial sequencing or amplification of species-specific DNA targets (e.g. coagulase, nuclease) directly from clinical material or isolated bacterial colonies, become the method of choice. Patients at risk of infection by S. aureus SCVs include cystic fibrosis patients (CF), patients with skin and foreign-body related infections and osteomyelitis, as they suffer from chronic staphylococcal infections and are subject to long-term antibiotic therapy. Molecular evidence of SCV development has not been found except for some random mutations of the thymidylate synthase gene (thyA) described in SCV S. aureus strains of CF patients. These variants are able to bypass the antibiotic effect of folic acid antagonists such as sulfonamides and trimethoprim. Resistance to gentamicin and aminoglycosides in the hemin or menadione auxotrophic SCVs was hypothesized as being due to decreased influx of the drugs into cells as a result of decreased ATP production and decreased electrochemical gradient on cell membranes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21253898     DOI: 10.1007/s12223-010-0089-3

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  69 in total

1.  Comparison of PCR-based methods for typing Staphylococcus aureus isolates.

Authors:  Artur Sabat; Natalia Malachowa; Jacek Miedzobrodzki; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 2.  Small-colony variants (SCVs) of staphylococci: a role in foreign body-associated infections.

Authors:  C von Eiff; K Becker
Journal:  Int J Artif Organs       Date:  2007-09       Impact factor: 1.595

3.  Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants.

Authors:  Frank Kipp; Barbara C Kahl; Karsten Becker; Ellen J Baron; Richard A Proctor; Georg Peters; Christof von Eiff
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Dwarf-colony variants of Staphylococcus aureus resistant to aminoglucoside antibiotics and to a fatty acid.

Authors:  R W Lacey
Journal:  J Med Microbiol       Date:  1969-08       Impact factor: 2.472

5.  Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species.

Authors:  Karsten Becker; Dag Harmsen; Alexander Mellmann; Christian Meier; Peter Schumann; Georg Peters; Christof von Eiff
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants.

Authors:  Beata Sadowska; Agnieszka Bonar; Christof von Eiff; Richard A Proctor; Magdalena Chmiela; Wieslawa Rudnicka; Barbara Róźalska
Journal:  FEMS Immunol Med Microbiol       Date:  2002-02-18

7.  Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease.

Authors:  C von Eiff; K Becker; D Metze; G Lubritz; J Hockmann; T Schwarz; G Peters
Journal:  Clin Infect Dis       Date:  2001-04-30       Impact factor: 9.079

8.  Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence.

Authors:  Lorena Tuchscherr; Vanessa Heitmann; Muzaffar Hussain; Dorothee Viemann; Johannes Roth; Christof von Eiff; Georg Peters; Karsten Becker; Bettina Löffler
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

9.  Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.

Authors:  Jonas Lannergård; Christof von Eiff; Gunnar Sander; Tina Cordes; Jochen Seggewiss; Georg Peters; Richard A Proctor; Karsten Becker; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2008-09-08       Impact factor: 5.191

10.  Physiological characterization of a heme-deficient mutant of Staphylococcus aureus by a proteomic approach.

Authors:  Christian Kohler; Christof von Eiff; Georg Peters; Richard A Proctor; Michael Hecker; Susanne Engelmann
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

View more
  37 in total

1.  Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione.

Authors:  Melissa A Dean; Randall J Olsen; S Wesley Long; Adriana E Rosato; James M Musser
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

2.  Biofilm-like aggregation of Staphylococcus epidermidis in synovial fluid.

Authors:  Kimberly Perez; Robin Patel
Journal:  J Infect Dis       Date:  2015-02-23       Impact factor: 5.226

3.  Drug-Resistant Staphylococcus aureus Strains Reveal Distinct Biochemical Features with Raman Microspectroscopy.

Authors:  Oscar D Ayala; Catherine A Wakeman; Isaac J Pence; Jennifer A Gaddy; James C Slaughter; Eric P Skaar; Anita Mahadevan-Jansen
Journal:  ACS Infect Dis       Date:  2018-06-25       Impact factor: 5.084

4.  SaeRS Is Responsive to Cellular Respiratory Status and Regulates Fermentative Biofilm Formation in Staphylococcus aureus.

Authors:  Ameya A Mashruwala; Casey M Gries; Tyler D Scherr; Tammy Kielian; Jeffrey M Boyd
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

5.  Survival of Staphylococcus epidermidis in Fibroblasts and Osteoblasts.

Authors:  Kimberly Perez; Robin Patel
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

6.  Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan.

Authors:  Joe Latimer; Sarah Forbes; Andrew J McBain
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

7.  Decreased susceptibility of Staphylococcus aureus small-colony variants toward human antimicrobial peptides.

Authors:  Regine Gläser; Karsten Becker; Christof von Eiff; Ulf Meyer-Hoffert; Jürgen Harder
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

8.  Artificial Selection for Pathogenicity Mutations in Staphylococcus aureus Identifies Novel Factors Relevant to Chronic Infection.

Authors:  Kathryn McLean; Elizabeth A Holmes; Kelsi Penewit; Duankun K Lee; Samantha R Hardy; Mingxin Ren; Maxwell P Krist; Kevin Huang; Adam Waalkes; Stephen J Salipante
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

9.  Isolation and characterization of small-colony variants of Ornithobacterium rhinotracheale.

Authors:  Mohammad Zahra; Miro Ferreri; Rashad Alkasir; Jinhua Yin; Bo Han; Jingliang Su
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

10.  A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

Authors:  Joe S Matarlo; Yang Lu; Fereidoon Daryaee; Taraneh Daryaee; Bela Ruzsicska; Stephen G Walker; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2016-03-07       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.